DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Uloric (Febuxostat) - Current Clinical Trials

 
 



Uloric Related Clinical Trials

Phase 3, Febuxostat, Allopurinol and Placebo-Controlled Study in Gout Subjects. [Completed]

The Blood Pressure Effects of Febuxostat in Patients Previously Treated With Allopurinol: A Pilot Study [Terminated]

Efficacy and Safety of Extended Release and Immediate Release Febuxostat in Participants With Gout [Recruiting]

Effects of Febuxostat on Adipokines and Kidney Disease in Diabetic Chronic Kidney Disease [Completed]

Effect of Febuxostat on Renal Function in Patients With Gout and Moderate to Severe Renal Impairment [Completed]

Efficacy and Safety of Extended Release and Immediate Release Febuxostat in Participants With Gout and Moderate Renal Impairment [Recruiting]

Study of Tranilast Alone or in Combination With Febuxostat in Patients With Hyperuricemia [Completed]

Febuxostat Versus Allopurinol Control Trial in Subjects With Gout [Completed]

Allopurinol Versus Febuxostat in Subjects Completing the Phase 3 Trials C02-009 or C02-010 [Completed]

Effect of Febuxostat on Joint Damage in Hyperuricemic Subjects With Early Gout [Completed]

Dose-Response, Safety and Efficacy of Febuxostat in Subjects With Gout [Completed]

Phase 1, Febuxostat XR Bioavailability Study [Recruiting]

Effect of Febuxostat on Blood Pressure [Completed]

Effect of Febuxostat Compared to Placebo on Exercise Tolerance in Participants With Chronic Stable Angina [Terminated]

The Effect of Uric Acid Lowering in Type 1 Diabetes [Recruiting]

Febuxostat Versus Allopurinol or Placebo in Patients With Hyperuricosuria and Calcium Oxalate Stones [Completed]

RDEA3170 and Febuxostat Drug Interaction Study [Completed]

Evaluate the PK, PD, and Safety of Arhalofenate in Combination With Febuxostat for Hyperuricemia in Patients With Gout [Completed]

Food Effect Study of Febuxostat XR in Healthy Participants [Completed]

Compare the Renal Protective Effects of Febuxostat and Benzbromarone [Recruiting]

Long-Term Safety of Febuxostat in Subjects With Gout. [Completed]

Effect of Antacid on Bioavailability of Febuxostat After Administration of a Febuxostat 80 mg Extended-Release Capsule [Completed]

RDEA3170 and Febuxostat Combination Study in Gout Subjects [Active, not recruiting]

Study of Febuxostat Effect on Blood Pressure in Patients With High Normal Blood Pressure [Completed]

Safety and Efficacy of Oral Febuxostat in Subjects With Gout [Completed]

Intensive Urate Lowering Therapy With Febuxostat in Comparison With Allopurinol on Cardiovascular Risk in Patients With Gout [Not yet recruiting]

Febuxostat, Blood Pressure and the Intrarenal Renin-Angiotensin System (RAS) [Completed]

An Assessment of Chronic Synovial-Based Inflammation and Its Role With Serum Urate Levels. [Completed]

Open Label Safety/Efficacy Study of Arhalofenate in Combination With Febuxostat for Hyperuricemia in Gout Patients [Completed]

Febuxostat for Tumor Lysis Syndrome Prevention in Hematologic Malignancies [Completed]

A Study to Evaluate Safety and Efficacy of Oral Febuxostat in Patients With Gout [Completed]

Febuxostat for Cerebral and caRdiorenovascular Events prEvEntion stuDy [Active, not recruiting]

the Effect of Febuxostat on Coronary Plaque Volume in Patients With Chronic Stable Angina and Hyperuricemia [Not yet recruiting]

Phase III Trial of Febuxostat in Korea Gout Patients [Completed]

Combination Treatment Study in Subjects With Tophaceous Gout With Lesinurad and Febuxostat [Completed]

A PD/Safety Study of RDEA3170 in Combination With Febuxostat for Treating Gout or Asymptomatic Hyperuricemia Patients [Completed]

Lesinurad and Febuxostat Combination Extension Study in Gout [Active, not recruiting]

The Cardiovascular Protective Effects of Febuxostat in Peritoneal Dialysis Patients [Recruiting]

Effects of Hyperuricemia Reversal on Features of the Metabolic Syndrome [Recruiting]

Clinical Study to Evaluate the Pharmacokinetic Characteristics Between TMX-67 and Feburic� in Healthy Volunteers [Completed]

Lesinurad Monotherapy in Gout Subjects Intolerant to Xanthine Oxidase Inhibitors [Completed]

Safety, Tolerability and Pharmacokinetic/Pharmacodynamic Characteristics of LC350189 [Completed]

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017